Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
12%
Africa South of the Sahara
18%
African Trypanosomiasis
9%
Anti-Bacterial Agents
9%
Antibodies
9%
Antigens
10%
Azithromycin
8%
Bacterial Vaginosis
14%
Belgium
51%
Blood Culture
10%
Burkina Faso
11%
Cambodia
24%
CD4 Lymphocyte Count
11%
Chikungunya virus
6%
Child
12%
Chlamydia trachomatis
6%
Ciprofloxacin
8%
Clinical Trials
7%
Cohort Studies
13%
Coinfection
12%
Confidence Intervals
8%
Cross-Sectional Studies
12%
Democratic Republic of the Congo
44%
Disease Outbreaks
15%
Eastern Africa
7%
Ebola Hemorrhagic Fever
8%
Enzyme-Linked Immunosorbent Assay
7%
Epidemics
6%
Ethiopia
36%
Falciparum Malaria
6%
Fever
14%
Fluoroquinolones
8%
Gambia
6%
Genotype
7%
Gonorrhea
12%
Guidelines
7%
Guinea
14%
Health
9%
Hepacivirus
13%
Hepatitis C
6%
HIV
100%
HIV Infections
22%
HIV-1
16%
HIV-2
6%
Immune Reconstitution Inflammatory Syndrome
11%
Incidence
7%
Income
9%
Infection
26%
Kenya
9%
Leishmaniasis
6%
Macrolides
8%
Malaria
42%
Microbiota
7%
Microscopy
11%
Mortality
9%
Multidrug-Resistant Tuberculosis
8%
Mycoplasma genitalium
6%
Neisseria
6%
Neisseria gonorrhoeae
17%
Parasites
12%
Peru
7%
Pharmaceutical Preparations
7%
Plasmodium
7%
Plasmodium falciparum
10%
Point-of-Care Systems
7%
Polymerase Chain Reaction
12%
Population
13%
Pre-Exposure Prophylaxis
23%
Retrospective Studies
11%
Rifampin
8%
Routine Diagnostic Tests
31%
Rwanda
15%
Safety
6%
Salmonella
8%
Salmonella typhi
8%
SARS Virus
7%
Schistosomiasis
8%
Serogroup
7%
Serum
6%
Sex Workers
6%
Sexual and Gender Minorities
18%
Sexual Behavior
7%
Sexually Transmitted Diseases
21%
Sierra Leone
6%
South Africa
13%
Syphilis
15%
Therapeutics
19%
Treatment Failure
7%
Treponema pallidum
7%
Tuberculosis
33%
Typhoid Fever
6%
Uganda
28%
Vaccination
6%
Viral Load
10%
Virus Diseases
11%
Viruses
7%
Visceral Leishmaniasis
34%
Western Africa
8%
Zambia
6%
Zika Virus
7%